Article
The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.
BJU international - 1 Oct 2026
Cheng Heather H, Maxwell Kara N, Salari Keyan, Cooperberg Matthew R, Follmer Kristin, Jeter Joanne M, Jun Grace, Lee Daniel J, Patel Hiten D, Schaeffer Edward M, Sokolova Alexandra O, Wolff Erika M, Lin Daniel W
Abstract excerpt
BACKGROUND: Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines-e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53. However, the optimal early detection strategy for gPV carriers, including use of age-adjusted PSA...
Read the complete abstract on PubMedTopics
- Humans
- Male
- Middle Aged
- Early Detection of Cancer
- Genetic Predisposition to Disease
